Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.
The Associate Director, Data Management plays a central role in delivering high quality, inspection-ready clinical trial data across Alumis’ development programs. This role will primarily support the Phase 3 program for envudeucitinib, a next-generation, highly selective oral TYK2 inhibitor for patients with moderate-to-severe plaque psoriasis. The Associate Director will be instrumental in enabling data deliveries that support a planned New Drug Application (NDA) submission to the FDA in the second half of 2026.
You will be joining Alumis at a pivotal and fast-paced stage of development. In this role, you will lead end-to-end data management activities for one or more late-stage clinical studies. You will partner closely with cross-functional teams and external vendors to ensure clinical data meets regulatory standards in a timely and high-quality manner to support key development and regulatory milestones. From managing database transfers and ongoing data review to driving timelines through database freeze and lock, you will drive late-stage processes that enable the advancement of therapies with the potential to meaningfully improve patients’ lives.
Study Leadership & Delivery
Data Quality & Review
Vendor & Cross-Functional Collaboration
Document & Inspection Readiness
Operational Excellence
Systems, Testing & Data Flow
This role is anchored at our South San Francisco, CA headquarters, and local candidates are strongly preferred. Remote candidates may be considered if they can maintain Pacific Time business hours and travel to HQ approximately once per month, or as business needs require.
The salary range for this position is $195,000 USD to $225,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.
Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.
Other benefits include:
We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevate, challenge and nurture one another along the way.
Alumis Inc. is an equal opportunity employer.
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.
Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.
Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.
Take the next step in your career journey